Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Critical Therapeutics to Present at the Pacific Growth Equities 2006 Life Sciences Growth Conference.


LEXINGTON, Mass. -- Critical Therapeutics therapeutics

Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry.
, Inc. (Nasdaq: CRTX), a biopharmaceutical company focused on the discovery, development and commercialization of products for respiratory, inflammatory and critical care diseases, will present at the Pacific Growth Equities 2006 Life Sciences Growth Conference on June 13, 2006 at 4:00 p.m. ET from the InterContinental in·ter·con·ti·nen·tal  
adj.
1. Extending or taking place between or among continents: intercontinental exploration; intercontinental cooperation.

2.
 Mark Hopkins Hotel in San Francisco San Francisco (săn frănsĭs`kō), city (1990 pop. 723,959), coextensive with San Francisco co., W Calif., on the tip of a peninsula between the Pacific Ocean and San Francisco Bay, which are connected by the strait known as the Golden .

Paul Rubin, M.D., President and Chief Executive Officer, will provide an update on the Company's strategy, operations and development pipeline. A live and archived webcast of this presentation will be available by logging on to the "Investors" section of the Company's website, www.crtx.com, and clicking the link labeled "Webcasts & Presentations."

About Critical Therapeutics

Critical Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of products for respiratory, inflammatory and critical care diseases. The Company owns worldwide rights to ZYFLO(R) (zileuton zileuton /zi·leu·ton/ (zi-loo´ton) an inhibitor of leukotriene formation, used as an antiasthmatic.
Zileuton (Zyflo) 
 tablets), as well as other formulations of zileuton. ZYFLO is the only 5-lipoxygenase inhibitor inhibitor /in·hib·i·tor/ (in-hib´i-tor)
1. any substance that interferes with a chemical reaction, growth, or other biologic activity.

2.
 approved for marketing by the U.S. Food and Drug Administration. The Company's commercialization efforts for ZYFLO are carried out by its specialty sales force. Critical Therapeutics also is developing treatments directed toward the severe inflammatory response in acute diseases and conditions that lead to admission to the emergency room or intensive care unit, and acute exacerbations of other chronic diseases that frequently lead to hospitalization hospitalization /hos·pi·tal·iza·tion/ (hos?pi-t'l-i-za´shun)
1. the placing of a patient in a hospital for treatment.

2. the term of confinement in a hospital.
. For more information, please visit www.crtx.com.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jun 7, 2006
Words:233
Previous Article:New Mobile Payment System Pioneering The Use Of Credit and Debit Cards For The Purchase of Digital and Ring Sounds.
Next Article:Danka Reports Fiscal Year 2006 Fourth Quarter and Year End Operating Results.
Topics:



Related Articles
Seattle Genetics to Present at Three Conferences in June.
Critical Therapeutics to Present at Conferences Hosted by Needham & Company and Pacific Growth Equities.
Illumina to Webcast Presentation at Pacific Growth Equities Life Sciences Conference.
Amgen Announces Webcast of First Quarter Financial Results.
C21 BioVentures Showcases a Host of Investment Opportunities; Investors Benefit from Discounted Delegate Fees.
Critical Therapeutics to Present at the FBR 2006 Growth Investor Conference on June 1, 2006 in New York City.
Illumina to Webcast Presentation at Pacific Growth Life Sciences Conference.
Seattle Genetics to Present at Two Upcoming Investor Conferences.
Amgen Announces Webcast of Second Quarter Financial Results.
BioPartnering Europe (BPE) Features Informative Sessions on the Hottest Themes in Biotech Today.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles